Scorpion Therapeutics
Boston, MA
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
scorpiontx.comCompany Details
Founded
- 2020
Employees
- Between 20 - 100 employees
Raised
- $420,000,000
Headquarters Location
- Boston, MA
Public
- No
Acquired
- Yes
CEO
Axel Hoos
Founders
- Gaddy GetzKeith FlahertyLiron Bar-PeledGary D. Glick
Company Collections
These are collections Scorpion Therapeutics is a part of. Click on the collection name to view similar companies.
Scorpion Therapeutics' Investors
Scorpion Therapeutics' Industries
Scorpion Therapeutics Headquarters Location
Total Amount Raised: $420,000,000
Scorpion Therapeutics' Investors
Scorpion Therapeutics Funding Rounds
Series C
$150,000,000
Series C Investors
Frazier Life SciencesLightspeed Venture PartnersOmega Fund ManagementOrbiMed AdvisorsWoodline PartnersAbingworthWellington ManagementWillett AdvisorsVida VenturesNextech InvestCasdin CapitalAtlas VentureLogos CapitalFidelitySurveyor CapitalBoxer CapitalEcoR1 CapitalInvusSeries B
$162,000,000
Series B Investors
Boxer CapitalEcoR1 CapitalVida VenturesAbingworthWoodline PartnersAtlas VentureWellington ManagementLogos CapitalInvusHenderson Global InvestorsOmega Fund ManagementNextech InvestOrbiMed AdvisorsCasdin CapitalSurveyor CapitalSeries A
$108,000,000
Series A Investors
Atlas VentureOmega Fund ManagementVida VenturesAbingworthPartners HealthCare InnovationMass General Brigham
Scorpion Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Scorpion Therapeutics.